[Thyroid function after mantle field radiation therapy (author's transl)].
48 patients with malignant lymphoma received a 60Co-radiation dose of 30 to 50 Gy using the mantle field technique. Thyroid function tests were performed 34 to 92 months after radiation therapy. One patient developed myxedema, ten (20.8%) had subclinical hypothyroidism and six (12.5%) latent hypothyroidism. The incidence of hypothyroidism after treatment of malignant lymphomas is summarized in a review of the literature. Discrepancies on the incidence of hypothyroidism were found, and their possible cause is discussed. Periodic examinations of all patients with thyroid radiation exposure are recommended. The examination can be limited to measurement of TSH concentration and palpation of the thyroid for nodules.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology; D008223:Lymphoma / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000209:etiology; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000528:radiation effects*; D013972:Thyrotropin / Q000097:blood
D003037:Cobalt Radioisotopes; D013972:Thyrotropin
Schilddrüsenfunktion nach thorakaler mantelfeldbestrahlung.